Key result
Among patients with STEMI undergoing primary percutaneous coronary intervention, 6-week outcomes demonstrated a 36% rate of major adverse cardiac events and a 5% all-cause mortality rate.
Why the study?
The study was conducted to clarify the characteristics and 6-week outcomes of patients with STEMI following PPCI in the Kurdistan Region of Iraq.
Observational (n=151)
No
Answers are grounded in this paper and cite their sources.
Primary percutaneous coronary intervention for STEMI is feasible and associated with reasonable short-term outcomes in the Kurdistan Region of Iraq.
Objective: This registry aims to clarify the characteristics and 6-weeks outcomes of patients with STEMI after PPCI in the region. Methods: Data from a total of 151 STEMI patients undergoing PPCI at Duhok heart center, Iraq from 2020 to 2021 was collected. Patient’s demographic, clinical and PPCI profiles were recorded. The major adverse cardiac events (MACE) and left ventricle ejection fraction (LVEF%) outcomes for 6 weeks period was registered. Results: Of the 151 consecutive patients with STEMI who underwent PPCI, 46 (30.4%) were <50 years old. Majority of patients were males and have clusters of cardiometabolic risk factors. 64% of cases attained Cath lab within first hour of initial chest pain. Almost 90% of STEMI cases were treated with stenting with TIMI3 in (94%). 80% of PPCI cases discharged home within 24 hours uneventfully. 6-weeks LVEF was preserved within normal range in 55% of cases. 36% had MACEs including impaired LVEF. All cause-mortality happened in 5%. 4% were Censored from follow up. The predictors of 6-weeks outcomes were depend on type/location of myocardial infarction, the culprit artery, TIMI flow post PCI and length of hospital stay. Conclusions: This registry has shown feasibility in doing PPCI with reasonable outcomes in the Region. Networking of capable centers of PPCI in the country is essential for augmenting the cardiac services and sharing the knowledge among cardiologists and people for better STEMI outcomes.
No takes yet. Share an insight, caveat, or question.
Mohammad et al. (2022) conducted an observational in ST-Segment Elevation Myocardial Infarction (STEMI) (n=151). Primary percutaneous coronary intervention (PPCI) was evaluated on 6-week major adverse cardiac events (MACE) including impaired LVEF. Among patients with STEMI undergoing primary percutaneous coronary intervention, 6-week outcomes demonstrated a 36% rate of major adverse cardiac events and a 5% all-cause mortality rate.
Synapse has enriched 10 related papers. Consider them for comparative context: